SCHEMBL9183004

SCHEMBL9183004

CC(=O)OC(CN1CCN(C(c2ccccc2)c2ccccc2)CC1)CN(C(C)=O)c1cccc2ncccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.44
▸ KMT2A Q03164 7/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ TP53 P04637 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ MEN1 O00255 6/20 0.40
▸ OPRM1 P35372 1/20 0.40
▸ OPRD1 P41143 1/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ FAAH O00519 1/20 0.38
▸ MGLL Q99685 1/20 0.38
▸ P2RX7 Q99572 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9188114 0.89 ABCB1 (0.49) ABCB1KMT2AALDH1A1LMNATP53
SCHEMBL9184822 0.82 ABCB1 (0.60) ABCB1KMT2AALDH1A1LMNATP53
SCHEMBL9180057 0.77 KMT2A (0.49) ABCB1KMT2AALDH1A1LMNATP53
SCHEMBL9184019 0.74 LMNA (0.47) ABCB1KMT2AALDH1A1LMNATP53
SCHEMBL9189012 0.72 ABCB1 (0.57) ABCB1KMT2AALDH1A1LMNATP53
SCHEMBL9181999 0.71 ABCB1 (0.49) ABCB1KMT2AALDH1A1MEN1
SCHEMBL9183346 0.70 ABCB1 (0.74) ABCB1KMT2AALDH1A1LMNATP53
SCHEMBL9186320 0.68 ABCB1 (0.59) ABCB1KMT2AALDH1A1LMNATP53
SCHEMBL9181122 0.68 ABCB1 (0.49) ABCB1KMT2AALDH1A1LMNATP53
SCHEMBL9181681 0.68 ABCB1 (0.49) ABCB1KMT2AALDH1A1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5405843-A Anticancer drug potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-04-11 — — US disclosed
EP-0363212-B1 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS (JP) 1995-01-04 — — EP disclosed
US-5204348-A Quinoline derivatives MITSUI TOATSU CHEMICALS INC. (JP) 1993-04-20 — — US disclosed
US-5112817-A Anticancer Drug Potentiators MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1992-05-12 — — US disclosed
EP-0363212-A2 Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-04-11 — — EP disclosed
Send feedback